Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Steel

Showing results (411-420 of 426) with videos related to

Pageof 43
Sort By:
Disease Markers|December 14, 1999
Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?D Stoppa-Lyonnet, M Caligo, D Eccles, et al.
Disease Markers|December 14, 1999
Cancer genetics services in EuropeS Hodgson, B Milner, I Brown, et al.
International Journal of Radiation Biology|November 14, 2002
The G2 chromosomal radiosensitivity assayP E Bryant, L Gray, A C Riches, et al.
British Journal of Cancer|September 12, 2014
Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancerM Michael, S Chander, J McKendrick, et al.
Journal of Medical Genetics|April 17, 2008
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancersD G Evans, K N Gaarenstroom, D Stirling, et al.
Plos Computational Biology|September 4, 2025
Ten simple rules for training by researchers for researchers in a rapidly evolving workforceMeirian Lovelace-Tozer, John Brown, Robert Clemens, et al.
Disease Markers|December 14, 1999
Insurance implications for individuals with a high risk of breast and ovarian cancer in EuropeP J Morrison, C M Steel, H F Vasen, et al.
British Journal of Cancer|February 22, 2000
Evidence of a founder BRCA1 mutation in ScotlandA Liede, B Cohen, D M Black, et al.
Disease Markers|December 14, 1999
Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast CancerP Møller, G Evans, N Haites, et al.
Journal of Medicinal Chemistry|September 14, 2007
Discovery and characterization of novel, potent, non-peptide parathyroid hormone-1 receptor antagonistsIain M McDonald, Carol Austin, Ildiko M Buck, et al.
Pageof 43

Showing results (411-420 of 426) with videos related to

Sort By:
Pageof 43
Disease Markers|December 14, 1999
Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?D Stoppa-Lyonnet, M Caligo, D Eccles, et al.
Disease Markers|December 14, 1999
Cancer genetics services in EuropeS Hodgson, B Milner, I Brown, et al.
International Journal of Radiation Biology|November 14, 2002
The G2 chromosomal radiosensitivity assayP E Bryant, L Gray, A C Riches, et al.
British Journal of Cancer|September 12, 2014
Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancerM Michael, S Chander, J McKendrick, et al.
Journal of Medical Genetics|April 17, 2008
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancersD G Evans, K N Gaarenstroom, D Stirling, et al.
Plos Computational Biology|September 4, 2025
Ten simple rules for training by researchers for researchers in a rapidly evolving workforceMeirian Lovelace-Tozer, John Brown, Robert Clemens, et al.
Disease Markers|December 14, 1999
Insurance implications for individuals with a high risk of breast and ovarian cancer in EuropeP J Morrison, C M Steel, H F Vasen, et al.
British Journal of Cancer|February 22, 2000
Evidence of a founder BRCA1 mutation in ScotlandA Liede, B Cohen, D M Black, et al.
Disease Markers|December 14, 1999
Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast CancerP Møller, G Evans, N Haites, et al.
Journal of Medicinal Chemistry|September 14, 2007
Discovery and characterization of novel, potent, non-peptide parathyroid hormone-1 receptor antagonistsIain M McDonald, Carol Austin, Ildiko M Buck, et al.
Pageof 43